MAPT and dementia: Even with the advent of the new molecular imaging probes, the role of the biomarkers of neurodegeneration is more valid than ever, since abnormal deposits of proteins like amyloid and tau in the brain can be asymptomatic for many years and do not represent per se the presence of dementia.